Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?

Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?

ObjectiveTo evaluate whether the combination of immune checkpoint inhibitor (ICI) with chemotherapy is more effective than ICI alone in the treatment of recurrent, locoregionally advanced, unresectable nasopharyngeal carcinoma (RAU-NPC), which has progressed after second line chemotherapy.Methods an...

Full description

Bibliographic Details
Main Authors:	Xin Zhou, XiaoShuang Niu, PeiYao Liu, Dan Ou, Yi Zhu, XiaoShen Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Immunology
Subjects:	immune checkpoint inhibitor recurrent nasopharyngeal carcinoma chemotherapy unresectable progression-free survival objective response rate
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.762663/full

Similar Items

Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer
by: PeiYao Liu, et al.
Published: (2020-04-01)

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study
by: Xiaoshuang Niu, et al.
Published: (2024-01-01)

Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
by: Yuming Zheng, et al.
Published: (2024-02-01)

Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland？
by: Xiaoshuang Niu, et al.
Published: (2023-10-01)

Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management
by: Xin Zhou, et al.
Published: (2021-01-01)

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
by: Xiaoshuang Niu, et al.
Published: (2021-12-01)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
by: Hui-Chuan Sun, et al.
Published: (2021-11-01)

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Weiwei Li, et al.
Published: (2022-08-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
by: Pei-Chang Lee, et al.
Published: (2020-01-01)

Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma
by: Qiao Li, et al.
Published: (2021-03-01)

The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis
by: Zongyu Liang, et al.
Published: (2023-01-01)

Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
by: Bahareh Farasati Far, et al.
Published: (2023-03-01)

Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy—Implications for Risk Stratification and Planning Optimization
by: Xin Zhou, et al.
Published: (2020-04-01)

Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research
by: Pei-Fen Zhang, et al.
Published: (2018-04-01)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
by: Naveen Kalra, et al.
Published: (2013-04-01)

Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer
by: Yanfen Zheng, et al.
Published: (2022-06-01)

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
by: Ranpu Wu, et al.
Published: (2021-07-01)

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
by: Gan L, et al.
Published: (2023-04-01)

Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
by: Zhang Mengqi, et al.
Published: (2023-11-01)

Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
by: Yin Long, et al.
Published: (2023-12-01)

Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma
by: Shuang Zhao, et al.
Published: (2021-10-01)

Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re‐analysis of a meta‐analysis
by: Shouhao Zhou, et al.
Published: (2023-02-01)

Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
by: Qing Lei, et al.
Published: (2022-09-01)

Is there a place for liver transplantation in cases with unresectable central cholangiocarcinoma?
by: Nicolae Bacalbașa, et al.
Published: (2018-11-01)

Laparoscopic gastric partitioning gastrojejunostomy for an unresectable duodenal malignant tumor
by: Matsumoto Toshifumi, et al.
Published: (2005-01-01)

Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy
by: Jiazhou Wang, et al.
Published: (2019-03-01)

Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
by: Zaisheng Ye, et al.
Published: (2021-06-01)

Intraoperative radiofrequency ablation for unresectable abdominal paraganglioma: a case report
by: Isabelle P. A. Magalhaes, et al.
Published: (2024-04-01)

Triplet‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis
by: Muyou Tian, et al.
Published: (2023-11-01)

A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma
by: Yao-Can Xu, et al.
Published: (2022-07-01)

Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis
by: Xue-Gang Yang, et al.
Published: (2022-07-01)

Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
by: Doris Helbig, et al.
Published: (2022-11-01)

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
by: Zuoyao Long, et al.
Published: (2023-01-01)

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!
by: Vijay Maruti Patil, et al.
Published: (2020-10-01)

Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
by: Xinyu Chen, et al.
Published: (2021-11-01)

The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma
by: Xiao‐Min Li, et al.
Published: (2022-09-01)

Therapeutic Effect of Elemene Combined with Chemoradiotherapy and Its Influence on Immune Function in Nasopharyngeal Carcinoma Patients
by: ZHOU Xingqin, et al.
Published: (2019-12-01)

Esophageal stenting for unresectable cancer (review of literature)
by: N. S. Popova, et al.
Published: (2021-01-01)

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study
by: Yue Han, et al.
Published: (2021-10-01)